WinSanTor Named Most Fundable Company by Pepperdine Graziadio Business School

Have you been diagnosed with peripheral neuropathy? We can help.

October 16, 2020, SAN DIEGO – WinSanTor is thrilled to announce that it was awarded a Silver designation on the Pepperdine Graziadio Business School’s third annual Most Fundable Companies® List.

WinSanTor competed against over 4,500 early-stage U.S. startups spanning all 50 states. All with less than $10 million in annual revenue and was named among a list of twenty. The Most Fundable Companies initiative is designed to educate founders on the investor diligence process. It also recognizes exceptional entrepreneurs who are seeking investment capital to fuel their company’s growth.

At WinSanTor, we are developing what may be the only disease-modifying treatment for peripheral neuropathy. A debilitating neurodegenerative condition that affects the lives of hundreds of millions of people.

“Since starting Company in 2011, we’ve been focused on the discovery and development of treatments for peripheral neuropathies. These include diabetic peripheral neuropathy, chemo- and HIV-induced peripheral neuropathy, among many others.” The Most Fundable Companies initiative provided us with a data-driven analysis. Not only did that enhance our company strategy but has also been incorporated into our fundraising activities. “It’s extremely validating that Pepperdine Graziadio Business School is recognizing entrepreneurs throughout the country. It is also providing resources to assist startups in securing private capital to accelerate meaningful innovation across industries and communities.”, said WinSanTor.

The Most Fundable Companies initiative involved a multi-phase assessment that evaluated several company variables. These include financial projections, market opportunity, intellectual property and the strength of the management team. They contributed to a fundability score. The initiative is powered by The Venture Alliance and companies were evaluated and selected based on their readiness for private investment.

As a winner on the Most Fundable Companies List, WinSanTor will be profiled on and will be featured in the December print issue of the magazine. For a complete list of the winners, visit, where you can also vote for WinSanTor as the “crowd favorite” through November 1.

WinSanTor Inc. is a San Diego-based clinical-stage biotechnology company focused on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo- and HIV-induced peripheral neuropathy, and others. Visit to learn more.

Disclaimers: The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It does not constitute investment advice, nor is it an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Sign up for our newsletter

Free to join.

Your privacy is very important to us. We will never share your information without your written consent.

WinSanTor is based in San Diego, California, USA

Share This Story, Choose Your Platform:

Related Posts

a red ribbon in a woman's hand against a red backdrop, symbolizing HIV awareness
HIV-Induced Peripheral Neuropathy

What is HIV-Induced Neuropathy?

Causes of HIV-induced neuropathy Neuropathy in individuals with HIV can result from various factors. The virus triggers inflammation that harms nerves, contributing to the condition. Certain drugs, referred to as

Have you been diagnosed with peripheral neuropathy? We can help.